Old Web
English
Sign In
Acemap
>
authorDetail
>
Nicholas S. Kirk
Nicholas S. Kirk
Illawarra Health & Medical Research Institute
Chemistry
Amide
Biochemistry
Semaxanib
Moiety
5
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Understanding IGF-II Action through Insights into Receptor Binding and Activation
2020
Cells
Andrew Blyth
Nicholas S. Kirk
Briony E. Forbes
Show All
Source
Cite
Save
Citations (7)
Prototyping kinase inhibitor-cytotoxin anticancer mutual prodrugs activated by tumour hypoxia: A chemical proof of concept study
2019
Bioorganic & Medicinal Chemistry Letters
Geraud N. Sansom
Nicholas S. Kirk
Christopher P. Guise
Robert F. Anderson
Jeff B. Smaill
Adam V. Patterson
Michael J. Kelso
Show All
Source
Cite
Save
Citations (3)
Unexpected synthesis of 3-imino-2-(pyrrol-2-yl) isatogen derivatives affords facile access to a 2-pyrrolyl isatogen
2017
Synthetic Communications
Nicholas S. Kirk
Geraud N. Sansom
Pichit Sudta
Sunit Suksamrarn
Anthony C. Willis
John B. Bremner
Michael J. Kelso
Show All
Source
Cite
Save
Citations (2)
Synthesis and preliminary evaluation of 5,7-dimethyl-2-aryl-3H-pyrrolizin-3-ones as angiogenesis inhibitors.
2016
Bioorganic & Medicinal Chemistry Letters
Nicholas S. Kirk
Anna Bezos
Anthony C. Willis
Pichit Sudta
Sunit Suksamrarn
Christopher R. Parish
Marie Ranson
Michael J. Kelso
Show All
Source
Cite
Save
Citations (6)
Synthesis, structural characterisation, and preliminary evaluation of non-indolin-2-one-based angiogenesis inhibitors related to sunitinib (Sutent®)
2013
Australian Journal of Chemistry
Pichit Sudta
Nicholas S. Kirk
Anna Bezos
Anthony Gurlica
Rhys Mitchell
Thomas Weber
Anthony C. Willis
Samran Prabpai
Palangpon Kongsaeree
Christopher R. Parish
Sunit Suksamrarn
Michael J. Kelso
Show All
Source
Cite
Save
Citations (9)
1